VELTASSA DIN 02481367
Status: Marketed
Holder: VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD
Molecule: PATIROMER (PATIROMER SORBITEX CALCIUM)
Available to quote
Health Canada record
| Active ingredient(s) | PATIROMER (PATIROMER SORBITEX CALCIUM) 16.8 G |
|---|---|
| Dosage form | Powder For Suspension |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | V03AE09 PATIROMER CALCIUM |
| Original market date | 27-Nov-2019 |
| Current status date | 27-Nov-2019 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing PATIROMER (PATIROMER SORBITEX CALCIUM)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02481359 | VELTASSA | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD | Powder For Suspension | PATIROMER (PATIROMER SORBITEX CALCIUM) 8.4 G | Marketed |
| 02481375 | VELTASSA | VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD | Powder For Suspension | PATIROMER (PATIROMER SORBITEX CALCIUM) 25.2 G | Approved |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21384 | 2018-10-03 | New Drug Submission (NDS) |